WASHINGTON – After advancing two bills aimed at boosting the Food and Drug Administration’s regulatory authority over compounding drugs, Senate lawmakers released a report calling for a uniform statutory framework to better protect public health.
The medical compounding company behind the fungal meningitis outbreak and a defendant in numerous lawsuits has filed for bankruptcy.
Published: November 26, 2012
Tags: Centers for Disease Control and Prevention, drug litigation, FDA, Food and Drug Administration, fungal meningitis, meningitis, NECC, New England Compounding Center, steroid injections, wrongful death
Lawsuits over the fungal meningitis outbreak from contaminated steroid injections are spreading nationwide as more cases are discovered.